Cronos (CRON) FCF Payout Ratio (2020 - 2025)
Cronos' (CRON) quarterly FCF Payout Ratio came in at 0.26 in Q4 2025, up 106.96% quarter-over-quarter from 3.79 in Q2 2025.
Cronos (CRON) FCF Payout Ratio (2020 - 2025) Analysis & Trends
Cronos' FCF Payout Ratio history runs 3 years deep, the most recent figure standing at 0.26 for Q4 2025.
- On a quarterly basis, FCF Payout Ratio changed N/A year-over-year to 0.26 in Q4 2025; TTM through Dec 2025 was 19.72, a 10333.4% increase from a year earlier, with the FY2025 full-year figure at 43.04, changed N/A from the prior year.
- FCF Payout Ratio climbed to 0.26 in Q4 2025 per CRON's latest filing, from 3.79 in the prior quarter.
- Across five years, FCF Payout Ratio topped out at 0.26 in Q4 2025 and bottomed at 3.79 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.77 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -10.50 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.40 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.26 |
| Jun 30, 2025 | -3.79 |
| Dec 31, 2022 | -0.02 |
| Dec 31, 2020 | -0.02 |